The Karolinska NeuroCOVID study protocol: Neurocognitive impairment, biomarkers and advanced imaging in critical care survivors.

Publication Year: 2022

DOI:
10.1111/aas.14062

PMCID:
PMC9111098

PMID:
35332517

Journal Information

Full Title: Acta Anaesthesiol Scand

Abbreviation: Acta Anaesthesiol Scand

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anesthesiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST TG is a recipient of the Grant for Multiple Sclerosis Innovation Award from Merck; not related. HZ has served at scientific advisory boards for Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, NervGen, AZTherapies, and CogRx, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, and Biogen, and is a co‐founder of Brain Biomarker Solutions in Gothenburg AB, which is a part of the GU Ventures Incubator Program (outside submitted work). FP has received research grants from Sanofi‐Genzyme, Merck KGaA and UCB, and fees for serving as Chair of DMC in clinical trials with Parexel Lundbeck and Roche."

Evidence found in paper:

"Funding information"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025